Atherosclerosis risk factors can impose aberrant DNA methylation patterns: A tale of traffic and homocvsteine

Current Opinion in Lipidology

Volumn 20, Issue 5, 2009, Pages 448-449

  Lund, Gertrud ^a,b   Zaina, Silvio ^a,b  

^a Cinvestav Unit Lrapuato   (Mexico)

^b UNIVERSITY OF GUANAJUATO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HOMOCYSTEINE;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DNA METHYLATION; HUMAN; NOTE; PRIORITY JOURNAL; RISK FACTOR;

ATHEROSCLEROSIS; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; HOMOCYSTEINE; HUMANS; RISK FACTORS;

EID: 73349117486     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283309928     Document Type: Note

References (13)

1. Waterland RA, Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr 2007; 27:363-388.
2. Berger SL The complex language of chromatin regulation during transcription. Nature 2007; 447:407-412. (Pubitemid 46816746)
3. KIm JK, Samaranayake M, Pradhan S. Epigenetic mechanisms in mammals. Cell Mol Life Sci 2009; 66:596-612. A recent, broad review of epigenetic mechanisms of transcription regulation.
4. Gallou-Kabanl C, Vlgé A, Gross MS, Junien C. Nutri-epigenomlcs: lifelong remodelling of our eplgenomes by nutritional and metabolic factors and beyond. Clin Chem Lab Med 2007; 45:321-327. (Pubitemid 46480913)
5. Gomes MV, Waterland RA. Individual epigenetic variation: when, why, and so what? Nestle Nutr Workshop Ser Pediatr Program 2008; 62:141-150.
6. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23:5293-5300.
7. Hiltunen MO, Turunen MP, Häkkinen TP, et al. DNA hypomethylatlon and methyltransferase expression in atherosclerotic lesions. Vase Med 2002; 7:5-11. (Pubitemid 34654067)
8. Lund G, Andersson L, Lauria M, et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 2004; 279:29147-29154.
9. Baccarelli A, Wright RO, Bollati V, et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med 2009; 179:572-578. An Important study showing that a CVD risk factor can have relatively fast effects on DNA methylation patterns of a significant portion of the human genome.
10. Yideng J, Jianzhong Z, Ying H, et al. Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol 2007; 26:603-611.
11. Huang Y-S, Zhi Y-F, Wang S-R. Hypermethylatlon of estrogen reoeptor-alpha gene in atheromatosis patients and its correlation with homocysteine. Pathophysiology 2009. [Epub ahead of print] A contribution to the controversial issue of whether Hey is a modifier of the epigenome and a CVD risk factor in general.
12. Post WS, Goldsohmldt-Clermont PJ, Wllhide CC, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999; 43:985-991.
13. Maron BA, Losoalzo J. Should hyperhomocystelnemla be treated in patients with atherosclerotic disease? Curr Atheroscler Rep 2007; 9:375-383.